Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys® technology.
Futura Medical is developing a portfolio of innovative products for two large markets, sexual health and pain.
MED3000
Products FAQs
Futura has a proven track record in delivery and completion of Research & Development projects up to value inflection points at which they are suitable for commercialisation partners.
WEBCASTS
Videos and webcasts
Shareholder centre
This section contains the latest RNS, news and videos.
Results for the Year ended 31 December 2023
Notice of Results and Investor Presentation
Eroxon to be available on prescription
Read more
35.40p (GB)
Change: -0.40 Last updated: 21:30
Share price information delayed at least 15 minutes
Download our Year end results for 2023
10 April 2024
07 February 2024
©2024 Futura Medical